Emergent BioSolutions to Participate in January 2015 Investor Conferences

ROCKVILLE, Md., Jan. 7, 2015 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company’s senior management team will participate in the following investor conferences in January 2015:

33^rd Annual J.P. Morgan Healthcare Conference
San Francisco
January 12, 2015
Presentation: 8:00AM Pacific
Noble Financial Capital Markets’ 11^th Annual Investor/Equity Conference
Florida
January 20, 2015
Presentation: 3:00PM Eastern

The company will be webcasting its participation in these conferences, which may include a discussion of the company’s recent business developments as well as its most recently reported financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under “Investors.”

About Emergent BioSolutions Inc.

Emergent BioSolutions is a specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about the company may be found at www.emergentbiosolutions.com.

CONTACT: Investors Contact:
         Robert G. Burrows
         Vice President, Investor Relations
         301-795-1877
         BurrowsR@ebsi.com

         Media Contact:
         Tracey Schmitt
         Vice President, Global Public Affairs
         and Corporate Responsibility
         301-795-1800
         SchmittT@ebsi.com

Emergent BioSolutions Inc.